Brief: CorMedix Pursues FDA Approval Of Defencath

CorMedix

08/09/2023 14:48

Sept 8 (Reuters) - CorMedix Inc  CRMD.O :
    * CORMEDIX INC - CORMEDIX IS PURSUING FDA APPROVAL OF
DEFENCATH
    * CORMEDIX INC -  FDA ASSIGNED PDUFA TARGET ACTION DATE OF
NOVEMBER 15 FOR DEFENCATH

Source text for Eikon:  ID:nGNX5Jld51 
Further company coverage:  CRMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))